Kansai Nerolac Paints (500165) Q4 15/16 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 15/16 earnings summary
21 Oct, 2026Executive summary
FY16 sales and operating revenue rose 9.3% YoY; normalized PBT increased 32.7%, while reported profit included a large gain from the Chennai land sale.
Growth initiatives included new decorative brand Soldier, automotive and industrial product launches, and planned capacity and R&D investments.
Financial highlights
Sales and operating revenue was ₹4,604.36 crore versus ₹4,211.64 crore; net sales/income from operations was ₹3,830.22 crore versus ₹3,549.06 crore.
Normal PBT before exceptional items was ₹529.37 crore versus ₹398.90 crore; PBT including the exceptional gain was ₹1,064.71 crore.
PAT was ₹891.10 crore versus ₹271.67 crore; the ₹535.34 crore land-sale gain was recorded as an exceptional item.
Recommended dividend was ₹3.05/share, including a special dividend of ₹1.25/share, versus ₹1.40/share last year.
Outlook and guidance
FY17 economic growth was expected to be similar to FY16; a 7.5% growth outlook, positive monsoon forecast and anticipated reforms were cited as demand tailwinds.
Planned Saykha, Gujarat facility: 42,000 MT annual capacity at estimated cost ₹350 crore; Goindwal Sahib, Punjab project: 38,000 MT at estimated cost ₹180 crore.
A Global R&D Centre at Vashi, Navi Mumbai was planned at an estimated cost of ₹40 crore.
Latest events from Kansai Nerolac Paints
- Cost control and cash generation offset pandemic-driven revenue decline and rising input costs.500165
Q4 20/21 - Cost controls lifted margins and PAT despite lower sales, as COVID-19 clouded the outlook.500165
Q4 19/20 - Revenue grew, profits eased, and acquisitions broadened the portfolio amid cost pressure.500165
Q4 18/19 - Sales and PBDIT advanced as capacity expansion met persistent cost pressures.500165
Q4 17/18 - Sales and operating profit grew as expansion advanced, offset by prior-year land-sale gains in PAT.500165
Q4 16/17 - FY15 PBT rose 29.9% as industrial coatings gained share and input costs eased.500165
Q4 14/15 - An accounting write-back lifted reported FY13 profit as costs and currency weighed on outlook.500165
Q4 12/13 - Revenue grew 10.8%; capacity investment advanced as input costs and weak demand pressured results.500165
Q4 13/14 - 26.4% sales growth, higher PAT, but inflation and price pass-through constrained outlook.500165
Q4 10/11